Vasalgel™ is an innovative contraceptive for men currently in development by Revolution Contraceptives. As Chief Operating Officer, I drive high level organization of corporate strategies, business operations and pre-clinical/clinical IVD programs and enable new social venture platforms, investor relations, product branding and drive our companies mission to launch an innovative product that will revolutionize the contraceptive industry. As Vice President, Global Clinical Development, I oversee all key competencies of global trials, product development and regulatory platforms, building strong relationships with investigators, regulators, CRO and manufacturing vendors. Acting PI and Sub-I on research platforms and grants, medical and technical writing for various business and clinical documents, grant proposals and legal contracts, strong medical/technical background with a synergistic blend of business and scientific acumen. Engaging in corporate presentations and public appearances for social and corporate ventures.